BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18397844)

  • 1. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
    Kleeff J; Michalski CW; Friess H; Büchler MW
    Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of locally advanced pancreatic cancer.
    Maheshwari V; Moser AJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Aug; 2(8):356-64. PubMed ID: 16265403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for pancreatic cancer: current status, future directions.
    Regine WF; Abrams RA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S10-3. PubMed ID: 17178279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of adjuvant therapy in resected pancreatic adenocarcinoma.
    Bergenfeldt M; Albertsson M
    Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
    Abrams RA
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S30-2. PubMed ID: 16399427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress.
    Evans DB; Wolff RA
    Ann Surg Oncol; 2011 May; 18(5):1224-8. PubMed ID: 21384245
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.
    Jafari M; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):751-60, xi. PubMed ID: 15350946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer.
    Garofalo MC; Kwok Y; Regine WF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):589-604, viii. PubMed ID: 15350936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for adjuvant chemoradiation for pancreatic cancer.
    Garofalo M; Flannery T; Regine W
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):403-16. PubMed ID: 16549335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.